Laufs U - Search Results

1

Katzmann JL, Laufs U. Katzmann JL, et al. Among authors: laufs u. Curr Opin Lipidol. 2024 Jun 1;35(3):117-125. doi: 10.1097/MOL.0000000000000919. Epub 2024 Jan 19. Curr Opin Lipidol. 2024. PMID: 38277255 Review.

2

Simulation study on LDL cholesterol target attainment, treatment costs, and ASCVD events with bempedoic acid in patients at high and very-high cardiovascular risk.

Katzmann JL, Becker C, Bilitou A, Laufs U. Katzmann JL, et al. Among authors: laufs u. PLoS One. 2022 Oct 27;17(10):e0276898. doi: 10.1371/journal.pone.0276898. eCollection 2022. PLoS One. 2022. PMID: 36301892 Free PMC article.

3

LDL cholesterol target attainment in cardiovascular high- and very-high-risk patients with statin intolerance: a simulation study.

Katzmann JL, Stürzebecher PE, Kruppert S, Laufs U. Katzmann JL, et al. Among authors: laufs u. Sci Rep. 2024 Jan 4;14(1):474. doi: 10.1038/s41598-023-50847-1. Sci Rep. 2024. PMID: 38172531 Free PMC article.

4

Proprotein convertase subtilisin/kexin type 9-inhibition across different patient populations.

Stürzebecher PE, Laufs U. Stürzebecher PE, et al. Among authors: laufs u. Curr Opin Lipidol. 2024 Mar 28. doi: 10.1097/MOL.0000000000000935. Online ahead of print. Curr Opin Lipidol. 2024. PMID: 38547336

5

Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP).

Banach M, Penson PE, Farnier M, Fras Z, Latkovskis G, Laufs U, Paneni F, Parini P, Pirro M, Reiner Ž, Vrablik M, Escobar C. Banach M, et al. Among authors: laufs u. Prog Cardiovasc Dis. 2023 Jul-Aug;79:2-11. doi: 10.1016/j.pcad.2023.03.001. Epub 2023 Mar 7. Prog Cardiovasc Dis. 2023. PMID: 36889490 Free article. Review.

6

[Treatment and LDL cholesterol adjustment in patients with high and very high cardiovascular risk in Germany compared with Europe - data from the SANTORINI registry].

Stürzebecher PE, Tünnemann-Tarr A, Tuppatsch K, Laufs U. Stürzebecher PE, et al. Among authors: laufs u. Dtsch Med Wochenschr. 2023 Apr;148(9):55-64. doi: 10.1055/a-2009-5077. Epub 2023 Mar 1. Dtsch Med Wochenschr. 2023. PMID: 36858065 Free PMC article. German.

7

Bempedoic acid lowers high-sensitivity C-reactive protein and low-density lipoprotein cholesterol: Analysis of pooled data from four phase 3 clinical trials.

Stroes ESG, Bays HE, Banach M, Catapano AL, Duell PB, Laufs U, Mancini GBJ, Ray KK, Sasiela WJ, Zhang Y, Gotto AM Jr. Stroes ESG, et al. Among authors: laufs u. Atherosclerosis. 2023 May;373:1-9. doi: 10.1016/j.atherosclerosis.2023.03.020. Epub 2023 Apr 3. Atherosclerosis. 2023. PMID: 37075696 Free article.

8

Lipoprotein(a) serum concentrations in children in relation to body mass index, age and sex.

Stürzebecher PE, Uttinger KL, Vogel M, Schlingmann M, Ceglarek U, Isermann B, Kiess W, Körner A, Laufs U. Stürzebecher PE, et al. Among authors: laufs u. Pediatr Res. 2024 Feb 28. doi: 10.1038/s41390-024-03108-4. Online ahead of print. Pediatr Res. 2024. PMID: 38418593

9

Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses.

Stürzebecher PE, Schorr JJ, Klebs SHG, Laufs U. Stürzebecher PE, et al. Among authors: laufs u. Atherosclerosis. 2023 Feb;367:24-33. doi: 10.1016/j.atherosclerosis.2023.01.014. Epub 2023 Jan 20. Atherosclerosis. 2023. PMID: 36764050 Free article.

10

[Cardiovascular pharmacotherapy in old age].

Schulz M, Trenk D, Laufs U. Schulz M, et al. Among authors: laufs u. Herz. 2023 Aug;48(4):325-336. doi: 10.1007/s00059-023-05191-5. Epub 2023 Jun 12. Herz. 2023. PMID: 37306716 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

571 results

Search Page